Therefore, analyzing the regulatory mechanism of ncRNA on EGFR expression is a new direction worth exploring to improve the radiosensitivity of GC, and the EGFR inhibitor derived from this is expected to be a selective and effective radiosensitizer for GC. The gene discussed is EGFR; the disease is gastric cancer.